This site is intended for health professionals only
Hospital Healthcare Europe
Register
Login
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
In depth
Views
Conference reports
Reviews & Research
Practice
Health technology
Sustainability
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Haematology
Immunology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Events
Upcoming events
On-demand learning
Clinical Excellence Catch-up
Partners
Register
Login
News
In depth
Views
Conference reports
Reviews & Research
Practice
Health technology
Sustainability
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Haematology
Immunology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Events
Upcoming events
On-demand learning
Clinical Excellence Catch-up
Partners
Register
Login
Home
>
Editor’s pick
Editor’s pick
Approval expected for Kamada drug
Pramipexole shows Parkinson’s hope
Announcement of transactions with shares and linked securities
Bayer Schering Pharma initiates phase III trial of regorafenib
NicOx reports first quarter 2010 financial results
Skin cancer drug “may prevent Aids”
‘White coat’ impact on blood pressure greater than thought
Novo Nordisk partners with international scientific community
Victory for Merck in Fosamax case
Boehringer Ingelheim and Micromet announce partnership
Drugs giants give profits forecast
New lung drug fails to win approval
« Previous
1
…
69
70
71
72
73
…
302
Next »
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
x
Search for: